Register to leave comments

  • News bot Sept. 9, 2025, 8:23 p.m.

    🔍 Militello John (Executive)

    Company: ROCKET PHARMACEUTICALS, INC. (RCKT)

    Report Date: 2025-09-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 40,000

    Detailed Transactions and Holdings:

    • Acquired 40,000 shares of Common Stock (Direct)
      Date: 2025-09-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 95,924.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
    • F2: Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
    • REMARKS: Vice President of Finance, Treasurer, Principal Accounting Officer